| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
21.16(B) |
| Last
Volume: |
1,036,753 |
Avg
Vol: |
1,862,399 |
| 52
Week Range: |
$65.11 - $83.64 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 411 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
114,998 |
114,998 |
238,111 |
483,765 |
| Total Sell Value |
$9,311,539 |
$9,311,539 |
$18,214,008 |
$36,874,758 |
| Total People Sold |
5 |
5 |
9 |
12 |
| Total Sell Transactions |
6 |
6 |
14 |
22 |
| End Date |
2024-06-20 |
2024-03-19 |
2023-09-19 |
2022-09-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Verstreken Jan |
Group President, International |
• • – |
2023-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,438 |
80,864 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2023-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,633 |
122,496 |
|
- |
|
| Griffin John M. |
General Counsel |
• • – |
2023-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,145 |
170,100 |
|
- |
|
| Anderson Erik S |
Div. Pres., Breast & Skeletal |
• • – |
2023-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
853 |
11,164 |
|
- |
|
| Mohtashami Nanaz |
Director |
• • – |
2023-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
745 |
745 |
|
- |
|
| Verstreken Jan |
Group President, International |
• • – |
2023-06-30 |
4 |
D |
$80.97 |
$26,072 |
D/D |
(322) |
78,426 |
|
- |
|
| Schneiders Jennifer M |
President, Diag. SolutionsOffi |
• – – |
2023-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,033 |
|
-16% |
|
| Mitchell Essex D |
Div. President, GYN Surgical |
• • – |
2023-05-05 |
4 |
S |
$83.73 |
$200,115 |
D/D |
(2,390) |
7,212 |
|
14% |
|
| Stewart Stacey D. |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
1,732 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
6,725 |
|
- |
|
| Stamoulis Christiana |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
43,900 |
|
- |
|
| Nawana Namal |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
18,221 |
|
- |
|
| Hantson Ludwig |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
9,520 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
131,355 |
|
- |
|
| Wendell Amy Mcbride |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
19,158 |
|
- |
|
| Garrett Scott T |
Director |
• • – |
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,465 |
67,039 |
|
- |
|
| Anderson Erik S |
Div. Pres., Breast & Skeletal |
• • – |
2023-03-01 |
4 |
D |
$79.06 |
$30,122 |
D/D |
(381) |
10,311 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2023-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,336 |
0 |
|
- |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2023-02-07 |
4 |
S |
$85.28 |
$778,445 |
D/D |
(9,128) |
14,298 |
|
6% |
|
| Cohn Benjamin Jordan |
Principal Accounting Officer |
• • – |
2023-02-07 |
4 |
OE |
$40.97 |
$373,974 |
D/D |
9,128 |
23,426 |
|
- |
|
| Stewart Stacey D. |
Director |
• • – |
2023-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
267 |
267 |
|
- |
|
| Hellmann Elisabeth A |
SVP, Human Resources |
• • – |
2022-12-14 |
4 |
S |
$76.40 |
$125,984 |
D/D |
(1,649) |
8,545 |
|
-10% |
|
| Griffin John M. |
General Counsel |
• • – |
2022-12-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,989 |
165,955 |
|
- |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2022-11-30 |
4 |
S |
$75.43 |
$2,534,365 |
D/D |
(33,500) |
2,313,970 |
|
-10% |
|
| Thornal Kevin R |
Group Pres, Global Diagnostics |
• • – |
2022-11-15 |
4 |
S |
$75.30 |
$1,440,062 |
D/D |
(19,118) |
62,368 |
|
-6% |
|
1708 Records found
|
|
Page 4 of 69 |
|
|
0.28 (0.34%) 
